Пулмозим

Пулмозим (Dornase Alfa) is an inhaled medication used to improve respiratory function in cystic fibrosis patients by thinning mucus. This enzyme therapy targets thickened airway secretions to ease breathing. Suitable for adults and children with CF-related lung issues.

Пулмозим is prescribed to help manage cystic fibrosis by reducing the viscosity of sputum in the lungs. It aids in clearing thick mucus, which can improve lung function and reduce respiratory complications. People often ask 'what is Pulmozyme used for' when seeking relief from CF-related breathing difficulties.

Users may notice easier breathing and reduced coughing as mucus becomes thinner and easier to clear. Some report improved sleep quality due to less congestion overnight. Effects vary by individual and consistent use is recommended for best results.

Keep the medication refrigerated and protect it from light. Always use the provided nebulizer system for administration. Discard any unused solution after opening to maintain sterility. Consult a healthcare provider if you experience worsening symptoms.

No major drug interactions are widely reported with Pulmozyme. However, concurrent use of other inhaled medications should be discussed with a doctor. Always inform healthcare providers about all medications being used to avoid potential conflicts.